Dr Clare Gould
Honorary (Fellow)
The Sir Peter MacCallum Department of Oncology
15 Scholarly works
2 Projects
HIGHLIGHTS
2026
Journal article
Advancing diagnostic targeted RNA sequencing for haematological malignancies within an Australian sample exchange program
DOI: 10.1016/j.pathol.2025.09.0032025
Research grants (ARC, NHMRC, MRFF)
Investigating Novel Determinants of Response to CAR T-Cell Therapy for Large B-Cell Lymphoma
2024
Journal article
Systemic diffuse large B-cell lymphoma involving the central nervous system has high rates of defective antigen presentation and immune surveillance
DOI: 10.3324/haematol.2023.2846002024
Journal article
Observations from a national sample exchange program for molecular haematology testing
DOI: 10.1016/j.pathol.2023.12.4132022
Journal article
Gene Expression Signatures for the Accurate Diagnosis of Peripheral T-Cell Lymphoma Entities in the Routine Clinical Practice
DOI: 10.1200/JCO.21.027072022
Conference Proceedings
Abstract A17: The immune checkpoints TIGIT and PD-1 are markedly upregulated in NLPHL compared to classical Hodgkin Lymphoma
DOI: 10.1158/2643-3249.lymphoma22-a172022
Research grants (other domestic)
Novel Strategies to Predict and Monitor Response to CAR T-Cell Therapy in DLBCL
RECENT SCHOLARLY WORKS
2021
Journal article
The NLPHL Tumor Microenvironment Is Markedly Enriched in the Tigit and PD-1 Signalling Axes Compared to Classical Hodgkin Lymphoma
DOI: 10.1182/blood-2021-1458402021
Journal article
Characterisation of immune checkpoints in Richter syndrome identifies LAG3 as a potential therapeutic target
DOI: 10.1111/bjh.177892021
Journal article
EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity
DOI: 10.1182/blood.20200085202020
Journal article
LAG3: A novel immune checkpoint expressed by multiple lymphocyte subsets in diffuse large B-cell lymphoma
DOI: 10.1182/bloodadvances.20190013902019
Journal article
The tumour microenvironment is immuno-tolerogenic and a principal determinant of patient outcome in EBV-positive diffuse large B-cell lymphoma
DOI: 10.1111/ejh.13274